Mei-Hsuan Tseng

发表

myelodysplastic syndrome and its stability during disease evolution mutation in patients with SRSF2 The clinical implication of

B. Ko, M. Yao, Chien-Yuan Chen, 2012 .

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution.

B. Ko, M. Yao, Chien-Yuan Chen, 2012, Blood.

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

Chieh-Yu Liu, B. Ko, M. Yao, 2009, Blood.

Clinical Trials and Observations

Chieh-Yu Liu, K. Trinkaus, P. Westervelt, 2022 .

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia

B. Ko, K. Kuo, M. Yao, 2011, Leukemia.

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

B. Ko, M. Yao, Yuan-Yeh Kuo, 2014, Blood Cancer Journal.

leukemia patients with intermediate-risk cytogenetics mutation is an unfavorable prognostic factor in acute myeloid TET2

Chieh-Yu Liu, B. Ko, K. Kuo, 2011 .

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes.

T. Lu, H. Tien, H. Hou, 2016, Blood advances.

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)

Chieh-Yu Liu, C. Li, M. Yao, 2016, Oncotarget.

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

Chieh-Yu Liu, B. Ko, M. Yao, 2014 .

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression

Chieh-Yu Liu, B. Ko, M. Yao, 2014, American journal of hematology.